Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects

J Chang, V P Werth

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Citations (Scopus)


Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.
Original languageEnglish
Title of host publicationExpert Review of Clinical Immunology
Place of PublicationV.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States
Number of pages13
Publication statusPublished - 2016

Publication series

NameExpert Review of Clinical Immunology


Dive into the research topics of 'Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects'. Together they form a unique fingerprint.

Cite this